Home
关于我们
产品中心
新闻资讯
技术文章
定制合成
联系我们
中文
产品中心
PRODUCTS
Current location:
Home
>>
产品中心
>>
抗体
PRODUCT CLASSIFICATION
News
NEWS
Application of bioactive small molecules in disease research
Green intelligence creates industry trends, Fuzhen Biology promotes low-carbon development of fine chemical industry
The monoclonal antibody industry is developing rapidly, and Fuzhen Biotechnology is improving its supply system for monoclonal antibody related raw materials
The global biopharmaceutical market continues to expand
Molecular building blocks are used as accelerators for the development of new drugs
Structural formula
Art.No.
Name
CAS
Pureness
CFZ02999
Crizanlizumab
1690318-25-2
95%
CFZ02998
Sacituzumab
1796566-95-4
95%
CFZ02997
Varisacumab
1610010-60-0
95%
CFZ02996
Maftivimab
2135632-36-7
95%
CFZ02995
Frunevetmab
1708936-80-4
95%
CFZ02994
Emapalumab
1709815-23-5
95%
CFZ02993
Rosmantuzumab
1684393-04-1
95%
CFZ02992
Tomaralimab
1449294-76-1
95%
CFZ02991
Brazikumab
1610353-18-8
95%
CFZ02990
Suvratoxumab
1629620-18-3
95%
Home
<<
···
14
15
16
17
18
···
16/59
>>
Last
QQ
QQ
Service Hotline:
15111215862
18229892877